Consuming alcohol while taking Ultrafolin Tablet may cause symptoms such as flushing, increased heart beat, nausea, thirst, chest pain and low blood pressure (Disulfiram reaction).
Information regarding the use of Ultrafolin Tablet during pregnancy is not available. Please consult your doctor.
Ultrafolin Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Ultrafolin Tablet does not usually affect your ability to drive.
Ultrafolin Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Ultrafolin Tablet may not be needed in these patients. Please consult your doctor.
Ultrafolin Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Ultrafolin Tablet may not be needed in these patients. Please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More